MACKENZIE FINANCIAL CORP - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 107 filers reported holding VISTAGEN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 5.83 and the average weighting 0.2%.

Quarter-by-quarter ownership
MACKENZIE FINANCIAL CORP ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$1,712
+21.0%
13,7300.0%0.00%
Q4 2022$1,415
-29.2%
13,7300.0%0.00%
Q3 2022$2,000
-83.3%
13,7300.0%0.00%
Q2 2022$12,000
-7.7%
13,730
+32.3%
0.00%
Q1 2022$13,000
-35.0%
10,3810.0%0.00%
Q4 2021$20,000
-35.5%
10,381
-7.6%
0.00%
Q3 2021$31,00011,2300.00%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Henrickson Nauta Wealth Advisors, Inc. 200,000$24,9400.02%
GSA CAPITAL PARTNERS LLP 1,275,215$1590.02%
TKG Advisors, LLC 134,860$16,8170.01%
JOHNSON & JOHNSON 190,494$23,7550.01%
GPS Wealth Strategies Group, LLC 253,205$31,5750.01%
Performa Ltd (US), LLC 90,000$11,2230.01%
Jackson Wealth Management, LLC 23,850$2,9740.00%
Garden State Investment Advisory Services LLC 30,000$3,7410.00%
MAI Capital Management 584,925$72,9400.00%
Twin Lakes Capital Management, LLC 12,500$1,5590.00%
View complete list of VISTAGEN THERAPEUTICS INC shareholders